Urethritis in men: Difference between revisions

Line 12: Line 12:
''Initial antimicrobial treatment is typically empiric, depending on risk for gonococcal versus nongonococcal urethritis''
''Initial antimicrobial treatment is typically empiric, depending on risk for gonococcal versus nongonococcal urethritis''


===[[Gonococcal]] (will also treat [[chlamydia]])===
===[[Gonococcal]]===
''will also treat [[chlamydia]]''
*[[Ceftriaxone]] 250 mg IM x 1, '''PLUS'''
*[[Ceftriaxone]] 250 mg IM x 1, '''PLUS'''
*[[Azithromycin]] 1 gm PO x 1
*[[Azithromycin]] 1 gm PO x 1


===Nongonococcal ([[Chlamydia]] most likely)===
===Nongonococcal===
''[[Chlamydia]] most likely pathogen''
*[[Azithromycin]] 1 gm) PO x 1, '''OR'''
*[[Azithromycin]] 1 gm) PO x 1, '''OR'''
*[[Doxycycline]] 100 mg  PO BID x 7 days
*[[Doxycycline]] 100 mg  PO BID x 7 days

Revision as of 10:30, 31 October 2017

Background

Genitourinary infection

(1) Human urinary system: (2) kidney; (3) renal pelvis; (4) ureter; (5) urinary bladder (6) urethra.
Additional structures: (7) adrenal gland; (8) renal artery and vein; (9) inferior vena cava; (10) abdominal aorta; (11) common iliac artery and vein; (12) liver; (13) large intestine; (14) pelvis.

"UTI" frequently refers specifically to acute cystitis, but may also be used as a general term for all urinary infections; use location-specific diagnosis.

Clinical Features

Differential Diagnosis

Dysuria

Evaluation

Management

Initial antimicrobial treatment is typically empiric, depending on risk for gonococcal versus nongonococcal urethritis

Gonococcal

will also treat chlamydia

Nongonococcal

Chlamydia most likely pathogen

Recurrent or Persistent

Antibiotics

Template:Urethritis antibiotics

Disposition

  • Outpatient

See Also

References